George Yancopoulos

Regeneron Pharmaceuticals

Regeneron is a biotech firm whose core innovation — the receptor trap — emerged from neurobiology, not pharmacology. It monetises that science via high-value partnerships and outsized government contracts, not broad platform dominance. Its success depends less on internal scale than on strategic leverage of public R&D funding.